TEAD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.462400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.877200E-01
Normal-vs-Stage2
3.559000E-01
Normal-vs-Stage3
3.456200E-01
Normal-vs-Stage4
4.163200E-01
Stage1-vs-Stage2
3.179200E-01
Stage1-vs-Stage3
2.343600E-01
Stage1-vs-Stage4
1.683990E-01
Stage2-vs-Stage3
5.194000E-01
Stage2-vs-Stage4
3.087000E-01
Stage3-vs-Stage4
8.263200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.377400E-01
Normal-vs-AfricanAmerican
4.577200E-01
Normal-vs-Asian
2.198600E-01
Caucasian-vs-AfricanAmerican
2.438800E-01
Caucasian-vs-Asian
1.532560E-01
AfricanAmerican-vs-Asian
9.742200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.260400E-01
Normal-vs-Female
3.757600E-01
Male-vs-Female
1.145190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.222000E-01
Normal-vs-Age(41-60Yrs)
3.597400E-01
Normal-vs-Age(61-80Yrs)
3.531000E-01
Normal-vs-Age(81-100Yrs)
2.821400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.513000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.032800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.199400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.391200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.665900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.141600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.045600E-01
Normal-vs-Daily Drinker
3.220400E-01
Normal-vs-Weekly Drinker
4.524200E-01
Normal-vs-Occasional Drinker
2.847200E-01
Normal-vs-Social Drinker
3.580200E-01
Non Drinker-vs-Daily Drinker
7.837800E-01
Non Drinker-vs-Weekly Drinker
4.275500E-02
Non Drinker-vs-Occasional Drinker
6.632600E-01
Non Drinker-vs-Social Drinker
3.903800E-01
Daily Drinker-vs-Weekly Drinker
1.367790E-01
Daily Drinker-vs-Occasional Drinker
5.414400E-01
Daily Drinker-vs-Social Drinker
6.212800E-01
Weekly Drinker-vs-Occasional Drinker
2.090400E-02
Weekly Drinker-vs-Social Drinker
2.790200E-01
Occasional Drinker-vs-Social Drinker
2.258400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.754800E-01
Normal-vs-Grade 2
8.452800E-01
Normal-vs-Grade 3
9.246400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.112960E-01
Grade 1-vs-Grade 3
4.053600E-01
Grade 1-vs-Grade 4
7.754800E-01
Grade 2-vs-Grade 3
2.295400E-01
Grade 2-vs-Grade 4
8.452800E-01
Grade 3-vs-Grade 4
9.246400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.541200E-01
Normal-vs-NonDiabetic
3.488400E-01
Diabetic-vs-NonDiabetic
9.346200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.870000E-01
Normal-vs-NoPancreatitis
3.499600E-01
Pancreatitis-vs-NoPancreatitis
6.606400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.073200E-01
Normal-vs-N1
3.705200E-01
N0-vs-N1
5.518200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.638200E-01
Normal-vs-TP53-NonMutant
2.156200E-01
TP53-Mutant-vs-TP53-NonMutant
1.659780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
